Issue Spotlight: Immuno-oncology: tools of tomorrow 2023

Issue Spotlight: Combination therapy development: emerging I-O therapeutic modalities and predictive technologies

Issue Spotlight: Leveraging the cutting-edge TME toolkit

Issue Spotlight: Nonclinical tools update: are they improving in their capabilities of predicting clinical responses?

Issue Spotlight: How to move towards precision I-O? Innovation in biomarker R&D

Issue Spotlight: Safety: what progress in understanding and addressing immune-related adverse events?

Issue Spotlight: Combination therapy development: strategic directions towards improving current I-O response rates

Issue Spotlight: Optimizing clinical development strategy for the rapidly evolving I-O field

Issue Spotlight: Novel target and pathways: driving new approaches to tackling the TME and resistance to I-O therapeutics

Issue Spotlight: Dissecting investor and market access trends and drivers for I-O R&D insights

Issue Spotlight: Anticipating immuno-oncology modality/platform development trends for 2022